氨氯地平联合沙利度胺治疗遗传性出血性毛细血管扩张症致罕见混合型肺动静脉畸形一例

A Case of Rare Mixed Pulmonary Arteriovenous Malformation Caused by Hereditary Hemorrhagic Telangiectasia Treated with Amlodipine Combined with Thalidomide

  • 摘要: 本文报道1例以反复鼻出血、直立位低氧血症为临床表现的青少年患者,其胸部影像表现为双肺多发分布的大小不等混杂密度结节,发泡试验、肺首过试验和吸纯氧公式法均证实患者存在肺内右向左分流。完善全基因组检测,提示其存在 SMAD4 基因突变,进一步行家系分析证实患者所患疾病为遗传性出血性毛细血管扩张症(hereditary hemorrhagic telangiectasia, HHT)。目前国际上针对该罕见病例的治疗缺少共识,参考国外文献相关个案报道,予患者试验性应用氨氯地平联合沙利度胺治疗,随访1 年后患者低氧症状明显改善。此病例的诊疗过程为HHT 致混合型PAVM患者的临床诊治提供了借鉴。

     

    Abstract: This article reports the case of an adolescent patient presenting with recurrent epistaxis and orthostatic hypoxemia. Chest imaging revealed multiple bilateral pulmonary nodules of varying sizes and mixed densities. The presence of intrapulmonary right-to-left shunting was confirmed through bubble contrast echocardiography, pulmonary first-pass perfusion imaging, and the pure oxygen inhalation formula method. Whole-genome sequencing identified a mutation in the SMAD4 gene, and subsequent family analysis confirmed the diagnosis of hereditary hemorrhagic telangiectasia (HHT).Currently, there is no international consensus on the management of such rare presentations. Based on relevant case reports in the literature, the patient was empirically treated with a combination of amlodipine and thalidomide. After one year of follow-up, significant improvement in hypoxemia was observed. The diagnostic and therapeutic process of this case offers valuable insights for the clinical management of patients with mixed-type PAVMs caused by HHT.

     

/

返回文章
返回